Package 62332-096-30

{"route": ["ORAL"], "spl_id": "8b09deb8-500f-428a-b588-6a238c7c553c", "openfda": {"nui": ["N0000175753", "N0000008486", "N0000175751", "N0000187061", "N0000000191"], "upc": ["0362332096305", "0362332095308"], "unii": ["U3H27498KS"], "spl_set_id": ["05cba628-b12c-44d8-89a8-3522fe417cc1"], "pharm_class_pe": ["Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "pharm_class_epc": ["Anti-epileptic Agent [EPC]", "Mood Stabilizer [EPC]"], "pharm_class_moa": ["Organic Cation Transporter 2 Inhibitors [MoA]", "Dihydrofolate Reductase Inhibitors [MoA]"], "manufacturer_name": ["Alembic Pharmaceuticals Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "30 TABLET, FOR SUSPENSION in 1 BOTTLE (62332-096-30)", "package_ndc": "62332-096-30", "marketing_start_date": "20140411"}, {"sample": false, "description": "100 TABLET, FOR SUSPENSION in 1 BOTTLE (62332-096-31)", "package_ndc": "62332-096-31", "marketing_start_date": "20140411"}, {"sample": false, "description": "1000 TABLET, FOR SUSPENSION in 1 BOTTLE (62332-096-91)", "package_ndc": "62332-096-91", "marketing_start_date": "20140411"}], "brand_name": "lamotrigine", "product_id": "62332-096_8b09deb8-500f-428a-b588-6a238c7c553c", "dosage_form": "TABLET, FOR SUSPENSION", "pharm_class": ["Anti-epileptic Agent [EPC]", "Decreased Central Nervous System Disorganized Electrical Activity [PE]", "Dihydrofolate Reductase Inhibitors [MoA]", "Mood Stabilizer [EPC]", "Organic Cation Transporter 2 Inhibitors [MoA]"], "product_ndc": "62332-096", "generic_name": "lamotrigine", "labeler_name": "Alembic Pharmaceuticals Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "lamotrigine", "active_ingredients": [{"name": "LAMOTRIGINE", "strength": "25 mg/1"}], "application_number": "ANDA201168", "marketing_category": "ANDA", "marketing_start_date": "20140411", "listing_expiration_date": "20271231"}